Number of the day - Medrob achieved US$77.6 m revenue

Based on their annual report, Microport Medrob closed a strong year:

"In terms of the surgical robot business, the Group achieved revenue of US$77.6 million during the Reporting Period, representing a substantial year-on-year increase of 114.2% (excluding the foreign exchange impact). Gross profit margin improved by 15 percentage points, while net loss narrowed by 60.7% year-on-year. Overseas, the business recorded sales revenue of US$56.0 million, representing a year-on-year increase of 286.6%, establishing itself as a core engine driving the performance growth of this segment. During the Reporting Period, the “hip-knee compatibility” function of the Honghu® surgical robot received CE certification. In addition, the Toumai® Remote Surgery System and the UniPath™ Electronic Bronchoscope Surgical Navigation System received NMPA approval. The Company is the first company in the world to have products approved for commercialization across all five major golden surgical tracks" 

Source: Microport